Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-18 5:32 pm Purchase | 2025-09-11 | 13D | Rapport Therapeutics, Inc. Common Stock RAPP | Sofinnova Venture Partners XI, L.P. ("SVP XI") | 1,947,579 4.200% | 1,947,579 (New Position) | Filing History |
| 2024-11-12 2:45 pm Purchase | 2024-09-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP | Sofinnova Venture Partners XI, L.P. ("SVP XI") | 1,696,752 5.100% | 1,696,752 (New Position) | Filing History |
| 2024-09-30 8:34 pm Purchase | 2024-09-27 | 13D | BIOAMBER INC, BIOAQ | Sofinnova Venture Partners XI, L.P. ("SVP XI") | 2,304,901 6.700% | 2,304,901 (New Position) | Filing History |
| 2024-06-14 3:59 pm Purchase | 2024-06-10 | 13D | Rapport Therapeutics, Inc. Common Stock RAPP | Sofinnova Venture Partners XI, L.P. ("SVP XI") | 1,951,562 5.500% | 1,951,562 (New Position) | Filing History |